This classification is supported by consistent findings that GDF-15 is associated with both disease-specific outcomes and all-cause mortality in the setting of various conditions, including cancer (21,22), stable coronary heart disease (14), atrial fibrillation (23,24), and acute coronary syndrome (10,25). This evidence concerns the gene GDF15 and acute coronary syndrome.